# Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.

> **NCT02632435** · NA · COMPLETED · sponsor: **Ottawa Hospital Research Institute** · enrollment: 56 (actual)

## Conditions studied

- Breast Cancer
- Cancer

## Interventions

- **DEVICE:** PICC
- **DEVICE:** PORT

## Key facts

- **NCT ID:** NCT02632435
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02632435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02632435, "Randomized Trial Standard of Care Vascular Access Strategies for (Neo)Adjuvant Trastuzumab-based Breast Cancer Treatment.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02632435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*